Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Mahlknecht

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Epigenetics|March 15, 2012
Clinical Epigenetics is now a fully open access journalUlrich Mahlknecht
Biochemical and Biophysical Research Communications|February 25, 2009
Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2Barbara Zschoernig, Ulrich Mahlknecht
Advances in Experimental Medicine and Biology|March 9, 2012
Involvement of sirtuins in life-span and aging related diseasesUlrich Mahlknecht, Barbara Zschoernig
Experimental and Therapeutic Medicine|September 21, 2012
Age-related changes in peripheral blood counts in humansUlrich Mahlknecht, Simone Kaiser
Haematologica|February 13, 2008
Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cellsUlrich Mahlknecht, Christiane Schönbein
International Journal of Molecular Medicine|January 22, 2008
Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulationNicole Engel, Ulrich Mahlknecht
Biochemical and Biophysical Research Communications|September 9, 2008
SIRTUIN 1: regulating the regulatorBarbara Zschoernig, Ulrich Mahlknecht
Molecular Medicine (Cambridge, Mass.)|November 2, 2007
Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteinsImke Bokelmann, Ulrich Mahlknecht
Carcinogenesis|June 28, 2011
Epigenetic regulation of cellular adhesion in cancerJudith Katto, Ulrich Mahlknecht
Clinical Epigenetics|March 15, 2012
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell linesAnne Sappok, Ulrich Mahlknecht
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Epigenetics|March 15, 2012
Clinical Epigenetics is now a fully open access journalUlrich Mahlknecht
Biochemical and Biophysical Research Communications|February 25, 2009
Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2Barbara Zschoernig, Ulrich Mahlknecht
Advances in Experimental Medicine and Biology|March 9, 2012
Involvement of sirtuins in life-span and aging related diseasesUlrich Mahlknecht, Barbara Zschoernig
Experimental and Therapeutic Medicine|September 21, 2012
Age-related changes in peripheral blood counts in humansUlrich Mahlknecht, Simone Kaiser
Haematologica|February 13, 2008
Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cellsUlrich Mahlknecht, Christiane Schönbein
International Journal of Molecular Medicine|January 22, 2008
Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulationNicole Engel, Ulrich Mahlknecht
Biochemical and Biophysical Research Communications|September 9, 2008
SIRTUIN 1: regulating the regulatorBarbara Zschoernig, Ulrich Mahlknecht
Molecular Medicine (Cambridge, Mass.)|November 2, 2007
Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteinsImke Bokelmann, Ulrich Mahlknecht
Carcinogenesis|June 28, 2011
Epigenetic regulation of cellular adhesion in cancerJudith Katto, Ulrich Mahlknecht
Clinical Epigenetics|March 15, 2012
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell linesAnne Sappok, Ulrich Mahlknecht
Pageof 6